Evaluation of Plasma Alpha Klotho Levels in Obese Cases: Plasma Alpha Klotho Levels in Obese Cases
Scindeks Assistant Scindeks Assistant — A system for serious journals and those aspiring to become one
PDF

Abstract

Background: Klotho is an anti-aging gene that lengthens life when excessively expressed and accelerates aging when disrupted. In our study, we will research the correlations between plasma α-Klotho (α-KL) protein levels with body mass index (BMI), carotid intima media thickness (CIMT), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), high-sensitivity c-reactive protein (hsCRP) and cholesterol values in obese patients.

Methods: This study was conducted in a single-centered and cross-sectional manner.

Results: The study was performed with a total of 90 participants, 35 women (38.9%) and 55 men (61.1%). Of participants included in the study, 30 were normal weight (33.3%) (Group 1), 30 were overweight (33.3%) (Group 2) and 30 were obese (33.3%) (Group 3). There were statistically significant differences in the α-KL protein (p=0.010), hsCRP (p<0.001), homeostasis model assessment of insulin resistance (HOMA-IR) (p=0.022), values of the study groups. There is no significant difference between the study groups in terms of CIMT (p=0.380), TOS (p=0.613), TAS (p=0.056) and, OSI (p=0.943) values.

Conclusions: In conclusion, in this study, the overweight group had α-KL protein values that were significantly higher than the obese group, while hsCRP values were significantly higher in the obese group compared to the overweight and normal weight groups. There were no significant differences for CIMT, TAS, TOS and, OSI values in the study groups.  There were no significant correlations between α-KL protein values with BMI, hsCRP, CIMT, TAS, TOS and OSI values of participants in the study.

Keywords

Array
DOI: 10.5937/jomb0-60664

References

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Downloads

Download data is not yet available.